Krystal Biotech KRYS
NASDAQ KRYS
$311.39 -8.74 (-2.73%)
As of: Oct 23, 2026 · 3:59 PM EDT

Krystal Biotech (KRYS) Long-Term Debt Issuances (2017)

Updated

Krystal Biotech's Long-Term Debt Issuances was $1.3 million in FY2017, up 13.4% from $1.15 million in FY2016.

Analysis

Krystal Biotech (KRYS) Long-Term Debt Issuances (2017) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $1.15 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Krystal Biotech 9.22 Bn 5.99 Bn 112.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 2.00 Mn
Mar 31, 2017 300,000.00
API Access

Krystal Biotech Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=KRYS&period=max&api_key=YOUR_API_KEY